(Q40050028)

English

Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic

scientific article published on 20 November 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit